Skip to content
healthcare.dev
Get a free key

FOSAPREPITANT DIMEGLUMINE

NDC 67184-0540, FOSAPREPITANT DIMEGLUMINE, injection, powder, lyophilized, for solution, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0540
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213106
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0540 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSAPREPITANT DIMEGLUMINE150 mg/5mL

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
67184-0540-1671840540011 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5bb41bcb-c775-4447-9bd0-d4c55ad110ea

Use it

Look up 67184-0540 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0540 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0540. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.